Amneal (AMRX) 10% Owner Tushar Patel Receives 12.76M Shares

What Happened
Tushar Bhikhubhai Patel, a reported 10% owner of Amneal Pharmaceuticals (AMRX), received 12,763,469 shares of Amneal Class A common stock on August 10, 2026. The shares were issued to a limited liability company managed by Patel as part of Amneal’s acquisition of Kashiv BioSciences, LLC. The Form 4 lists this as an acquisition/award (transaction code A); no per-share price was reported for these issued shares.

Key Details

• Transaction date: 2026-08-10 (Form 4 filed 2026-08-12; filing appears timely).
• Transaction type/code: Grant/other acquisition (A). Price per share: N/A.
• Shares received by Patel’s LLC: 12,763,469 shares of Class A common stock.
• Consideration reported for the overall acquisition: $375,000,000 in cash (subject to adjustments) plus 28,942,098 shares of Amneal Class A common stock (the sellers collectively received those shares). Patel’s LLC received 12,763,469 of those shares (see footnote).
• Shares owned after transaction: Not specified on the Form 4.
• Notable: Patel is a 10% owner — these shares were received as part of a corporate acquisition, not an open-market purchase or sale by an executive.

Context
This was corporate deal consideration: Amneal’s subsidiary acquired 100% of Kashiv, and part of the purchase price was paid in Amneal stock. For retail investors, note this is issuance related to an acquisition (transfer of seller equity), not a personal buy or sell that signals insider sentiment. No immediate sale or disposition of these newly issued shares is reported in this filing.